Evidence map›Paper›PMID 19900755›Full record

ArticleUltrasound in medicine & biology2010

Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes.

Denise A B Smith, Sampada S Vaidya, Jonathan A Kopechek, Shao-Ling Huang, Melvin E Klegerman, David D McPherson, Christy K Holland

Open access · greenAbstract read
In one paragraph

Article in Ultrasound in medicine & biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 80 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Thrombolytic Agents: Nanocarriers in Controlled Release.Small (Weinheim an der Bergstrasse, Germany) · 2020
    Review
  8. Review
  9. Article
  10. Recent strategies on targeted delivery of thrombolytics.Asian journal of pharmaceutical sciences · 2019
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Efficacy of histotripsy combined with rt-PA in vitro.Physics in medicine and biology · 2016
    Article
  18. Article
  19. Article
  20. Sonothrombolysis.Advances in experimental medicine and biology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Denise A B SmithDepartment of Biomedical Engineering, University of Cincinnati, Cincinnati, OH, USA. denise.smith@uc.edu
Sampada S Vaidya
Jonathan A Kopechek
Shao-Ling Huang
Melvin E Klegerman
David D McPherson
Christy K Holland
The University of Texas Health Science Center at Houston · USUniversity of Cincinnati · USUniversity of Cincinnati Medical Center · US

Funding

Ultrasound-Assisted Thrombolysis for Stroke TherapyR01NS047603 · NINDS · UNIVERSITY OF CINCINNATI · PI HOLLAND, CHRISTY K. · 2004 to 2018
$7.5M
Echogenic Targeted Liposomes:Transfection/Drug DeliveryR01HL074002 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2004 to 2013
$5.3M
NHLBI NIH HHS HL074002NHLBI NIH HHS R01 HL074002NINDS NIH HHS NS047603NINDS NIH HHS R01 NS047603
6 · The paper itself

Abstract

Echogenic liposomes (ELIP) were developed as ultrasound-triggered targeted drug or gene delivery vehicles (Lanza et al. 1997; Huang et al. 2001). Recombinant tissue-type plasminogen activator (rt-PA), a thrombolytic, has been loaded into ELIP (Tiukinhoy-Laing et al. 2007). These vesicles have the potential to be used for ultrasound-enhanced thrombolysis in the treatment of acute ischemic stroke, myocardial infarction, deep vein thrombosis or pulmonary embolus. A clinical diagnostic ultrasound scanner (Philips HDI 5000; Philips Medical Systems, Bothell, WA, USA) equipped with a linear array transducer (L12-5) was employed for in vitro studies using rt-PA-loaded ELIP (T-ELIP). The goal of this study was to quantify ultrasound-triggered drug release from rt-PA-loaded echogenic liposomes. T-ELIP samples were exposed to 6.9-MHz B-mode pulses at a low pressure amplitude (600 kPa) to track the echogenicity over time under four experimental conditions: (1) flow alone to monitor gas diffusion from the T-ELIP, (2) pulsed 6.0-MHz color Doppler exposure above the acoustically driven threshold (0.8 MPa) to force gas out of the liposome gently, (3) pulsed 6.0-MHz color Doppler above the rapid fragmentation threshold (2.6 MPa) or (4) Triton X-100 to rupture the T-ELIP chemically as a positive control. Release of rt-PA for each ultrasound exposure protocol was assayed spectrophotometrically. T-ELIP were echogenic in the flow model (5 mL/min) for 30 min. The thrombolytic drug remained associated with the liposome when exposed to low-amplitude B-mode pulses over 60 min and was released when exposed to color Doppler pulses or Triton X-100. The rt-PA released from the liposomes had similar enzymatic activity as the free drug. These T-ELIP are robust and echogenic during continuous fundamental 6.9-MHz B-mode imaging at a low exposure output level (600 kPa). Furthermore, a therapeutic concentration of rt-PA can be released by fragmenting the T-ELIP with pulsed 6.0-MHz color Doppler ultrasound above the rapid fragmentation threshold (1.59 MPa). (E-mail: denise.smith@uc.edu).

Indexed as

UltrasonicsAnimalsCattleContrast MediaDiffusionFibrinolytic AgentsLiposomesRecombinant ProteinsSerum Albumin, BovineThrombolytic TherapyTissue Plasminogen ActivatorUltrasonography, Doppler, ColorUltrasonography, Doppler, PulsedContrast MediaFibrinolytic AgentsLiposomesRecombinant ProteinsSerum Albumin, BovineTissue Plasminogen Activator

Identifiers

PMID19900755
PMCPMC3037723
OpenAlexW2037638904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.